Literature DB >> 4547522

B-cell suppression of delayed hypersensitivity reactions.

S I Katz, D Parker, J L Turk.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4547522     DOI: 10.1038/251550a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  124 in total

1.  A novel mechanism of B cell-mediated immune suppression through CD73 expression and adenosine production.

Authors:  Hiroaki Kaku; Kai Fan Cheng; Yousef Al-Abed; Thomas L Rothstein
Journal:  J Immunol       Date:  2014-11-12       Impact factor: 5.422

2.  The role of antigen-presenting cells in the regulation of delayed-type hypersensitivity. I. Spleen dendritic cells.

Authors:  Y Morikawa; M Furotani; K Kuribayashi; N Matsuura; K Kakudo
Journal:  Immunology       Date:  1992-09       Impact factor: 7.397

3.  Studies on the role of suppressor cells in specific unresponsiveness to DNCB.

Authors:  L Polak
Journal:  Immunology       Date:  1976-09       Impact factor: 7.397

4.  CD22 expression mediates the regulatory functions of peritoneal B-1a cells during the remission phase of contact hypersensitivity reactions.

Authors:  Hiroko Nakashima; Yasuhito Hamaguchi; Rei Watanabe; Nobuko Ishiura; Yoshihiro Kuwano; Hitoshi Okochi; Yoshimasa Takahashi; Kunihiko Tamaki; Shinichi Sato; Thomas F Tedder; Manabu Fujimoto
Journal:  J Immunol       Date:  2010-03-24       Impact factor: 5.422

5.  Dengue virus-induced thymus-derived suppressor cells in the spleen of mice.

Authors:  P Tandon; U C Chaturvedi; A Mathur
Journal:  Immunology       Date:  1979-12       Impact factor: 7.397

6.  The role of antibodies in the regulation of delayed-type hypersensitivity.

Authors:  Y Morikawa; K Kuribayashi; F Yoshikawa; K Fujita; A Mizushima; K Kakudo
Journal:  Immunology       Date:  1991-09       Impact factor: 7.397

7.  TSPAN33 is a novel marker of activated and malignant B cells.

Authors:  Van Phi Luu; Peter Hevezi; Felipe Vences-Catalan; José Luis Maravillas-Montero; Clayton Alexander White; Paolo Casali; Luis Llorente; Juan Jakez-Ocampo; Guadalupe Lima; Natalia Vilches-Cisneros; Juan Pablo Flores-Gutiérrez; Leopoldo Santos-Argumedo; Albert Zlotnik
Journal:  Clin Immunol       Date:  2013-08-15       Impact factor: 3.969

8.  Cyclophosphamide intensifies the acquisition of allergic contact dermatitis in mice rendered B-cell deficient by heterologous anti-IgM antisera.

Authors:  H C Maguire; L Faris; W Weidanz
Journal:  Immunology       Date:  1979-06       Impact factor: 7.397

Review 9.  Next-generation regulatory T cell therapy.

Authors:  Leonardo M R Ferreira; Yannick D Muller; Jeffrey A Bluestone; Qizhi Tang
Journal:  Nat Rev Drug Discov       Date:  2019-09-20       Impact factor: 84.694

10.  Effect of cyclophosphamide on delayed hypersensitivity to Staphylococcus aureus in mice.

Authors:  C S Easmon; A A Glynn
Journal:  Immunology       Date:  1977-11       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.